Survival outcomes with immune checkpoint inhibitors in metastatic upper tract urothelial carcinoma: Real-world data from second-line and maintenance treatment
Miriam Cotaina, Geòrgia Anguera(Hospital de Sant Pau), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Carlos A. Reyes, Alejandra Romano, Mikel Portu, Alberto Fernández(Universidad Complutense de Madrid), M.A. Molina, J. Sanz(Hospital de Sant Pau), F. Bosma, Sofía Sánchez(Instituto Nacional de Ciencias Neurológicas), Pablo Maroto(Hospital de Sant Pau)
Cited by 0
Related Papers
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
|European Journal of Cancer|2012|588
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients
|Blood|2013|189
Human immunodeficiency virus‐associated plasmablastic lymphoma
|Cancer|2012|178